Faller Douglas Vincent 4

What Happened
Douglas V. Faller, Chief Medical Officer of Imunon, received an award of 1,308 shares on July 2, 2026. The shares were issued at $1.91 per share for a total reported value of $2,498. This was an award/grant (transaction code A) — a compensation issuance, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-02; Filing date (Form 4): 2026-07-07 (filed within the 2 business-day window for Form 4).
• Price per share: $1.91; Total reported value: $2,498.
• Shares acquired: 1,308 (award/grant).
• Shares owned after transaction: Not specified in the information provided.
• Footnote: F1 — stock was granted in lieu of cash for a portion of base salary.
• No 10b5-1 plan, tax-withholding, or sale information indicated in this filing.

Context
Grants received in lieu of cash salary are routine compensation and don’t necessarily signal insider buying conviction. For retail investors, purchases (direct buys) can be more indicative of bullish sentiment; compensation awards are primarily a payroll/retention matter.